{"schema_version":"1","generated_at":"2026-11-21T04:22:56.870Z","data_as_of":null,"url":"https://www.findmykol.com/kol/houman-vaghefi","json_url":"https://www.findmykol.com/kol/houman-vaghefi/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"houman-vaghefi","name":"Houman Vaghefi","credential":"MD, PhD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Goshen Health","institution_url":"https://www.findmykol.com/institution/goshen-health","city":"Goshen","state":"IN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Houman Vaghefi is an Oncology physician affiliated with Goshen Health. OpenAlex indexes 22 publications with 286 citations (h-index 8).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":22,"cited_by_count":286,"h_index":8,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":19,"program_years":{"first":2021,"last":null},"rows_total":24,"shown":3,"withheld":21,"rows":[{"payer":"Tempus AI, Inc","program_year":2025,"amount_usd":290.49,"payment_count":9},{"payer":"Myriad Genetic Laboratories, Inc.","program_year":2025,"amount_usd":41.04,"payment_count":2},{"payer":"Merck Sharp & Dohme LLC","program_year":2025,"amount_usd":32.17,"payment_count":2}],"source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Genitourinary & hormones","share_pct":100,"classes_total":1,"classes":[{"class":"alpha-Adrenergic Blocker","setting":"prescribed","share_pct":100,"drugs":[{"name":"Tamsulosin Hcl","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":22,"shown":5,"withheld":17,"matched_by":"OpenAlex author record","recent":[{"title":"Abstract PS15-03: Breast complications in patients who received intraoperative radiation therapy compared to other forms of radiation therapy following breast conserving surgery","year":2021,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.sabcs20-ps15-03","status":"verified"},{"title":"Abstract P5-18-12: Effectiveness of Oncotype DX DCIS scoring in a community setting","year":2019,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.sabcs18-p5-18-12","status":"verified"},{"title":"EP1191 Recurrent vaginal mucosal melanoma treated with salvage hypofractionated external beam radiotherapy and interstitial brachytherapy","year":2019,"journal":"International Journal of Gynecological Cancer","source_url":"https://doi.org/10.1136/ijgc-2019-esgo.1228","status":"verified"},{"title":"Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study","year":2017,"journal":"The Lancet. Gastroenterology & hepatology","source_url":"https://doi.org/10.1016/s2468-1253(17)30012-2","status":"verified"},{"title":"Radium-223 in a Community Setting for Castration Resistant Prostate Cancer","year":2017,"journal":"Cancer and Clinical Oncology","source_url":"https://doi.org/10.5539/cco.v6n1p44","status":"verified"}],"source":"works"},"contact":{"address_1":"200 HIGH PARK AVE","city":"Goshen","state":"IN","zip":"465264810","phone":"574-364-2888","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":21,"publications":17}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-08-08","provider_certified":"2023-08-08","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}